Showing 681-690 of 2321 results for "".
Are We Overlooking Skin Cancer in Ethnic Minorities?
https://practicaldermatology.com/issues/supplements/are-we-overlooking-skin-cancer-in-ethnic-minorities/21718/Skin cancers in Hispanic and African American patients may be detected at more advanced stages, leading to poorer prognoses and long-term outcomes compared to non-Hispanic whites.A Practical Approach to Home UVB Phototherapy for the Treatment of Generalized Psoriasis
https://practicaldermatology.com/topics/psoriasis/a-practical-approach-to-home-uvb-phototherapy-for-the-treatment-of-generalized-psoriasis/21926/Specialists review the basics of choosing ideal patients for home UVB, delineate key aspects of patient education, and provide detailed information on currently available phototherapy equipment.Clinical Conversations: Risks vs Benefits of JAK Inhibitors
https://practicaldermatology.com/series/jak-inhibitors-in-practice/clinical-conversations-risks-vs-benefits-of-jak-inhibitors/20108/Clinical data for JAK inhibitors show clear benefits for many patients. But these drugs are associated with certain risks and class warnings. Matt Zirwas, MD and Adelaide Hebert, MD describe how they weigh risks, educate patients, and optimize long-term management.Simple Ways to Implement Treatment Packages and Reap the Possible Benefits
https://practicaldermatology.com/topics/practice-management/simple-ways-to-implement-treatment-packages-and-reap-the-possible-benefits/23461/Tips for incorporating and pricing aesthetic treatment packages that benefit patients and your practice.Fillers for the Décolletage Area
https://practicaldermatology.com/topics/practice-management/fillers-for-the-dcolletage-area/21113/Fillers offer patients an alternative to device-based interventions for chest rejuvenation.o, MDDWTV Extra: Phase 3 Data on Roflumilast for AD, PsO
https://practicaldermatology.com/programs/practical-dermatology/dwtv-extra-phase-3-data-on-roflumilast-for-ad-pso/35925/Study investigator Melinda Gooderham, MD, talks about the Phase 3 trials of roflumilast cream 0.15% for adults and children down to age 6 with atopic dermatitis and roflumilast foam 0.3% for patients older than 12 with psoriasis of the scalp and body.Isotretinoin Online: Avoid Risk and Assure Safe Access
https://practicaldermatology.com/topics/practice-management/isotretinoin-online-avoid-risk-and-assure-safe-access/21441/Patients are buying the drug online without a prescription. Here's what dermatologists need to know to help protect patients and themselves.Lasers and EBDs: Considerations for Ethnic Skin
https://practicaldermatology.com/conferences/asds-2022-annual-meeting/lasers-and-ebds-considerations-for-ethnic-skin/20145/Monica Li, MD reviews evidence-based practices for using lasers, energy-based devices and minimally invasive procedures to manage benign dermatoses to treat patients with skin of color. She discusses the importance of engaging patients in appropriate pre- and post-treatment care to reduce potentialWhat Branding Is and Isn’t (and Why You Should Care)
https://practicaldermatology.com/topics/practice-management/what-branding-is-and-isnt-and-why-you-should-care/23776/Your brand will directly impact the kind of patients your practice attracts.DermWireTV: AbbVie's Science of Skin Panel, Monkeypox Warning, Recommendations on Skin Cancer Detection Devices, UV Filters and Aquatic Life
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-abbvies-science-of-skin-panel-monkeypox-warning-recommendations-on-skin-cancer-detection-devices-uv-filters-and-aquatic-life/20131/“The Science of Skin: United Beyond the Surface” program sponsored by AbbVie brings together leading dermatologists and patients or caregivers of patients with dermatologic disease to explore the burden of skin diseases on diverse populations and the need for optimized treatment approaches. Seemal D